scispace - formally typeset
Open AccessJournal ArticleDOI

Diagnostic Potential of Saliva: Current State and Future Applications

Reads0
Chats0
TLDR
Saliva has the potential to become a first-line diagnostic sample of choice owing to the advancements in detection technologies coupled with combinations of biomolecules with clinical relevance as mentioned in this paper, however, these technologies have not yet been integrated into current clinical practice and work flow.
Abstract
BACKGROUND: Over the past 10 years, the use of saliva as a diagnostic fluid has gained attention and has become a translational research success story. Some of the current nanotechnologies have been demonstrated to have the analytical sensitivity required for the use of saliva as a diagnostic medium to detect and predict disease progression. However, these technologies have not yet been integrated into current clinical practice and work flow. CONTENT: As a diagnostic fluid, saliva offers advantages over serum because it can be collected noninvasively by individuals with modest training, and it offers a cost-effective approach for the screening of large populations. Gland-specific saliva can also be used for diagnosis of pathology specific to one of the major salivary glands. There is minimal risk of contracting infections during saliva collection, and saliva can be used in clinically challenging situations, such as obtaining samples from children or handicapped or anxious patients, in whom blood sampling could be a difficult act to perform. In this review we highlight the production of and secretion of saliva, the salivary proteome, transportation of biomolecules from blood capillaries to salivary glands, and the diagnostic potential of saliva for use in detection of cardiovascular disease and oral and breast cancers. We also highlight the barriers to application of saliva testing and its advancement in clinical settings. SUMMARY: Saliva has the potential to become a first-line diagnostic sample of choice owing to the advancements in detection technologies coupled with combinations of biomolecules with clinical relevance.

read more

Citations
More filters
Journal ArticleDOI

Wearable biosensors for healthcare monitoring.

TL;DR: Although wearable biosensors hold promise, a better understanding of the correlations between analyte concentrations in the blood and noninvasive biofluids is needed to improve reliability.
Journal ArticleDOI

The human circadian metabolome.

TL;DR: The data suggest that there is a strong direct effect of the endogenous circadian clock on multiple human metabolic pathways that is independent of sleep or feeding, and they identify multiple potential small-molecule biomarkers of human circadian phase and sleep pressure.
Journal ArticleDOI

The microfluidics of the eccrine sweat gland, including biomarker partitioning, transport, and biosensing implications.

TL;DR: Reports here are microfluidic models for eccrine sweat generation and flow which are coupled with review of blood-to-sweat biomarker partition pathways, therefore providing insights such as how biomarker concentration changes with sweat flow rate.
References
More filters
Journal ArticleDOI

Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer.

TL;DR: The findings support that transcriptomic and proteomic signatures in saliva can serve as biomarkers for the non-invasive detection of breast cancer.
Journal ArticleDOI

Structural features of salivary function.

TL;DR: Identifying the functional domains of salivary proteins is vital in understanding the mechanisms of action and this information can be exploited in the development of therapeutic agents.
Journal ArticleDOI

Identification of protein components in human acquired enamel pellicle and whole saliva using novel proteomics approaches.

TL;DR: The results showed that whole saliva and pellicle have more complex protein patterns than those of glandular secretions.
Journal ArticleDOI

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients

TL;DR: Multivariate analyses in subgroups of node-negative and -positive patients, pre- and post-menopausal patients, and their combinations, showed that tumours with high cathepsin-D values had a significantly poor relapse-free survival, with relative hazard rates ranging from 1.3 to 1.5, compared with tumour extracts with lowCathepsInD levels.
Journal ArticleDOI

Identification of parotid salivary biomarkers in Sjögren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis

TL;DR: The salivary proteomic profile of SS is a mixture of increased inflammatory proteins and decreased acinar proteins when compared with non-SS.
Related Papers (5)